Company / Current Assets per Share
SUTRO BIOPHARMA, INC. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$18.17
FY2025
5-year range
$4.78 / $18.17
FY2021-FY2025
Trend
+222.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +223% YoY in FY2025, a notable deviation from the 7-year average annual change of +40%.
Based on SEC 10-K filings.
18.17 in FY2025 with a 5-year CAGR of +2.1%.
Improved from $7.33 to $18.17 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +33.6%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 222.9% year-over-year.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.17 | +222.9% |
| FY2024 | $5.63 | -23.2% |
| FY2023 | $7.33 | -3.8% |
| FY2022 | $7.62 | +59.6% |
| FY2021 | $4.78 | -70.8% |
| FY2020 | $16.37 | +191.0% |
| FY2019 | $5.63 | -98.8% |
| FY2018 | $451.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026